ESC Premium Access

Translating data to practice: aspirin in high-risk patient subgroups

Event: ESC CONGRESS 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 2 September 2019
Time: 13:00 - 14:00

Session

5 presentations in this session

Welcome and introduction

Speaker: Professor P. Henry (Paris, FR)
Thumbnail

Aspirin in patients with diabetes: primary prevention, secondary prevention or both?

Speaker: Professor U. Laufs (Leipzig, DE)
Speaker: Doctor F. Andreotti (Rome, IT)
Thumbnail

Summary

Speaker: Professor P. Henry (Paris, FR)
Thumbnail

Looking beyond patient age: the role of aspirin in cardiovascular risk management

Speaker: Doctor F. Andreotti (Rome, IT)
Speaker: Professor U. Laufs (Leipzig, DE)
Thumbnail

Closing remarks

Speaker: Professor M. Gaziano (Boston, US)
Thumbnail

7 speakers from this session

Professor Patrick Henry

AP-HP - Hospital Lariboisiere, Paris (France)
2 presentations
0 follower

Professor Ulrich Laufs

Leipzig University Hospital, Leipzig (Germany)
27 presentations
0 follower

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)
19 presentations
0 follower

Professor Patrick Henry

AP-HP - Hospital Lariboisiere, Paris (France)
2 presentations
0 follower

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)
19 presentations
0 follower

Professor Ulrich Laufs

Leipzig University Hospital, Leipzig (Germany)
27 presentations
0 follower

Professor Mike Gaziano

, Boston (United States of America)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk